Cambridge, MA 10/25/10—Helicos BioSciences has amended its patent infringement suit against Pacific Biosciences (see IBO 9/30/10), naming Illumina and Life Technologies as additional defendants. The suit alleges willful infringement of four patents for sequencing-by-synthesis methods using labeled nucleotides. “After a careful examination of the sequencing products and technologies offered by Illumina and Life Technologies, we […]
Menlo Park, CA 10/26/10; Washington, DC 10/26/10; New York, NY 10/27/10—DNA sequencer developer Pacific Biosciences completed its IPO (see IBO 8/31/10, 10/15/10) on October 26, selling 12.5 million shares of its common stock at $16 per share, which was the mid-range of its pricing. The sale raised $200 million, according to an SEC filing. Shares […]
Cambridge, MA 10/14/10; Washington, DC 10/15/10—Helicos BioSciences has appointed Dr. Ivan Trifunovich as president and CEO. He served as a senior consultant to the Board and was elected executive chairman last month. Previously, he served as senior vice president of molecular diagnostics firm Third Wave Technologies. Helicos BioSciences also announced the launch of a technology-licensing […]
Cleveland, OH 10/1/10; Quebec City, Canada 10/1/10—EXFO has sold its Life Sciences and Industrial Division to private equity firm The Riverside Company for $24.3 million in cash. The business supplies high-intensity UV illumination products, which are used in microscopes and life science instruments, as well as curing products. It will be renamed the Lumen Dynamics […]
Santa Clara, CA 10/13/10—Cell Biosciences has agreed to acquire Convergent Bioscience for $12 million in cash. Convergent Bioscience provides systems based on imaging capillary electrophoresis for quality control measurements during protein biologics production. Based in Toronto, Canada, Convergent Bioscience has 45 employees and is expected to have 2010 revenues of close to $8 million. “Our […]
San Diego, CA and Ottawa, Canada 10/14/10—Fate Therapeutics announced that it has signed a three-year collaboration and licensing agreement with BD Biosciences for the development and commercialization of induced pluripotent stem cell technologies for drug discovery and development. The companies will jointly develop products that BD Biosciences will commercialize. The agreement includes exclusive licenses to […]
Hopkinton, MA 10/12/10—Caliper Life Sciences announced that it has renewed its supply agreement with Agilent Technologies for microfluidic chips. Caliper will be Agilent’s exclusive supplier for seven years. “Agilent represents our largest OEM customer and accounted for over 15% of our total microfluidics business in 2009,” said Caliper President and CEO Kevin Hrusovsky. “We expect […]
Washington, DC 10/4/10—DNA sequencer developer Pacific Biosciences has updated its IPO filing with the SEC, stating that it plans to offer 12,500,000 shares of common stock at a price of $15–$17 per share. The company expects proceeds of $182.5 million. Of this amount, $60–$70 million would be used for applications of SMRT technologies, $40–$60 million […]
London, UK 10/8/10; London, UK 10/13/10—Instem Life Science Systems, a developer of software for early drug-development safety assessment, has commenced trading of its stock on the London Stock Exchange’s AIM market. The company raised £9.15 million ($14.5 million = £0.63 = $1) through a placement of 5,228,376 new ordinary shares at a price of £0.175 […]
Kalispell, MT 10/5/10—Applied Instruments Technologies (AIT) has been acquired from Hamilton Sundstrand by the Thompson Group of Companies for an undisclosed amount. AIT is a manufacturer and marketer of process analytical instruments, including the Analect FTIR, MGA MS and FXi GC systems. “The opportunity to organize AIT as a standalone company will allow us to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
